Cordatus Wealth Management’s MetLife MET Stock Holding History

Cordatus Wealth Management’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14,215	Closed	-$824K	–	156
2023 Q1	$824K	Buy	+14,215	New	+$959K	1.05%	38

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cordatus Wealth Management's MET Position: Q2 2023 in Review

Cordatus Wealth Management sold out of MetLife (MET) in Q2 2023, closing a stake of 14,215 shares — an estimated $824K sold.

Cordatus Wealth Management first reported a position in MET in Q1 2023 and held it in 1 quarter. The position peaked at $824K in Q1 2023. 1,170 funds tracked by Wall St. Rank hold MET as of Q2 2023.

Cordatus Wealth Management reported no remaining MetLife position as of Q2 2023 after selling out during the quarter.
Cordatus Wealth Management sold 14,215 MetLife shares in Q2 2023, an estimated $824K.
Cordatus Wealth Management first reported a position in MetLife in Q1 2023 and held it in 1 quarter.
Cordatus Wealth Management's MetLife position peaked at $824K in Q1 2023.
1,170 funds tracked by Wall St. Rank held MetLife as of Q2 2023.

Based on Cordatus Wealth Management's 13F filing for Q2 2023, filed 14 Jul 2023.